Antipsychotic-Induced Dysphagia
نویسندگان
چکیده
منابع مشابه
Antipsychotic-induced hyperprolactinemia.
Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can interfere with the functioning of reproductive, endocrine, and metabolic systems. As antipsychotic agents are increasingly used for both United States Food and Drug Administration-approved and nonapproved indications, many individuals are at risk for developing an...
متن کاملAcute antipsychotic-induced akathisia revisited.
Akathisia remains one of the most prevalent and distressful antipsychotic-induced adverse events. Effective and well-tolerated treatment is a major unmet need in akathisia that merits a search for new remedies. Accumulating evidence indicates that agents with marked serotonin-2A receptor antagonism may represent a new class of potential anti-akathisia treatment.
متن کاملAtypical antipsychotic induced obsessive-compulsive symptoms.
Recently, we came across an interesting case where Mr. A, a 26 year old Malay man with resistant schizophrenia, paranoid subtype, developed atypical antipsychotic induced obsessive-compulsive symptoms. Various attempts to treat him with conventional antipsychotics and risperidone had failed because he developed intolerable extrapyramidal side effects. Hence, he was started on clozapine. His psy...
متن کاملAntipsychotic-induced Hyperprolactinemia: Pathophysiology and Clinical Consequences
Hyperprolactinemia is one of the major adverse effects of antipsychotic agents. Although it is predominantly associated with the use of conventional or typical agents, atypical agents also cause varying degrees of hyperprolactinemia. Clinical manifestations, which tend to be underrecognized, are the result of the direct action of prolactin on its target tissues and of the sequelae of hypogonadi...
متن کاملPharmacogenetics of antipsychotic-induced side effects
Currently available antipsychotic drugs (APDs) carry significant though highly variable, liability to neurologic and metabolic side effects. Pharmacogenetics approaches offer the possibility of identifying patient-specific biomarkers for predicting risk of these side effects. To date, a few single nucleotide polymorphisms (SNPs) in a handful of genes have received convergent support across mult...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Primary Care Companion For CNS Disorders
سال: 2015
ISSN: 2155-7780
DOI: 10.4088/pcc.15l01792